Bruce Linton joins Midas Letter to discuss his strategy going forward within the cannabis space. Mr Linton believes that psychedelics have been poorly governed worldwide not allowing their therapeutic potentially to be fully explored. As psychedelic-assisted psychotherapy is looked into more, Mr Linton now owns roughly 10 percent of Mind Medicine Australia. Mr Linton also outlines a number of other subcategories within the cannabis space he is involved with such as animal specific CBD products and multi-state operators. His recent investment in SLANG Worldwide and the company's vision for its CPG-based cannabis business model is also all discussed.
Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today. James West and Ed Milewski provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEO’s of all public companies and analysts with the highest reputations in the business.